| Controlling protein translocation through nanopores with bio-inspired fluid walls EC Yusko, JM Johnson, S Majd, P Prangkio, RC Rollings, J Li, J Yang, ... Nature nanotechnology 6 (4), 253-260, 2011 | 754 | 2011 |
| Targeted next generation sequencing identifies markers of response to PD-1 blockade DB Johnson, GM Frampton, MJ Rioth, E Yusko, Y Xu, X Guo, RC Ennis, ... Cancer immunology research 4 (11), 959-967, 2016 | 484 | 2016 |
| Real-time shape approximation and fingerprinting of single proteins using a nanopore EC Yusko, BR Bruhn, OM Eggenberger, J Houghtaling, RC Rollings, ... Nature nanotechnology 12 (4), 360-367, 2017 | 458 | 2017 |
| ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial JM Wrangle, V Velcheti, MR Patel, E Garrett-Mayer, EG Hill, JG Ravenel, ... The Lancet Oncology 19 (5), 694-704, 2018 | 402 | 2018 |
| Applications of biological pores in nanomedicine, sensing, and nanoelectronics S Majd, EC Yusko, YN Billeh, MX Macrae, J Yang, M Mayer Current opinion in biotechnology 21 (4), 439-476, 2010 | 389 | 2010 |
| Fractionated radiation therapy stimulates antitumor immunity mediated by both resident and infiltrating polyclonal T-cell populations when combined with PD-1 blockade SJ Dovedi, EJ Cheadle, AL Popple, E Poon, M Morrow, R Stewart, ... Clinical Cancer Research 23 (18), 5514-5526, 2017 | 350 | 2017 |
| Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: an exploratory multi-omic analysis A Snyder, T Nathanson, SA Funt, A Ahuja, J Buros Novik, MD Hellmann, ... PLoS medicine 14 (5), e1002309, 2017 | 314 | 2017 |
| T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma AC Hopkins, M Yarchoan, JN Durham, EC Yusko, JA Rytlewski, ... JCI insight 3 (13), e122092, 2018 | 234 | 2018 |
| Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities SK Subudhi, A Aparicio, J Gao, AJ Zurita, JC Araujo, CJ Logothetis, ... Proceedings of the National Academy of Sciences 113 (42), 11919-11924, 2016 | 226 | 2016 |
| Comprehensive T cell repertoire characterization of non-small cell lung cancer A Reuben, J Zhang, SH Chiou, RM Gittelman, J Li, WC Lee, J Fujimoto, ... Nature communications 11 (1), 603, 2020 | 203 | 2020 |
| TCR repertoire intratumor heterogeneity in localized lung adenocarcinomas: an association with predicted neoantigen heterogeneity and postsurgical recurrence A Reuben, R Gittelman, J Gao, J Zhang, EC Yusko, CJ Wu, R Emerson, ... Cancer discovery 7 (10), 1088-1097, 2017 | 198 | 2017 |
| Electroosmotic flow can generate ion current rectification in nano-and micropores EC Yusko, R An, M Mayer Acs Nano 4 (1), 477-487, 2010 | 181 | 2010 |
| Concurrent PD-1 blockade negates the effects of OX40 agonist antibody in combination immunotherapy through inducing T-cell apoptosis RK Shrimali, S Ahmad, V Verma, P Zeng, S Ananth, P Gaur, RM Gittelman, ... Cancer immunology research 5 (9), 755-766, 2017 | 157 | 2017 |
| Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetes HR Seay, E Yusko, SJ Rothweiler, L Zhang, AL Posgai, ... JCI insight 1 (20), e88242, 2016 | 133 | 2016 |
| Ibrutinib therapy increases T cell repertoire diversity in patients with chronic lymphocytic leukemia Q Yin, M Sivina, H Robins, E Yusko, M Vignali, S O’Brien, MJ Keating, ... The Journal of Immunology 198 (4), 1740-1747, 2017 | 131 | 2017 |
| Single-particle characterization of Aβ oligomers in solution EC Yusko, P Prangkio, D Sept, RC Rollings, J Li, M Mayer ACS nano 6 (7), 5909-5919, 2012 | 130 | 2012 |
| Force is a signal that cells cannot ignore EC Yusko, CL Asbury Molecular biology of the cell 25 (23), 3717-3725, 2014 | 120 | 2014 |
| The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma D Agdashian, M ElGindi, C Xie, M Sandhu, D Pratt, DE Kleiner, WD Figg, ... Cancer Immunology, Immunotherapy 68, 599-608, 2019 | 119 | 2019 |
| Multivariate analyses of amyloid-beta oligomer populations indicate a connection between pore formation and cytotoxicity P Prangkio, EC Yusko, D Sept, J Yang, M Mayer Public Library of Science 7 (10), e47261, 2012 | 111 | 2012 |
| TCR sequencing can identify and track glioma-infiltrating T cells after DC vaccination MS Hsu, S Sedighim, T Wang, JP Antonios, RG Everson, AM Tucker, L Du, ... Cancer immunology research 4 (5), 412-418, 2016 | 69 | 2016 |